You are viewing: US Brain Monitoring Market analysis
Part of: Brain Monitoring Market (Global)

The US Brain Monitoring Market was valued at $1048.7 Million in 2023 and projected to reach to $1327.5 Million by 2028, representing a compound annual growth rate of 4.8%. The US brain monitoring market is positioned for sustained growth through 2028, supported by increasing neurological disease burden and technological innovation in monitoring devices.

US Brain Monitoring Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Brain Monitoring Market Trends and Insights

  • The US market is driven by increasing prevalence of neurological disorders, rising adoption of advanced monitoring technologies, and growing healthcare investments in neurocritical care.
  • In the US, demand for non-invasive and portable brain monitoring devices has accelerated, supported by favorable reimbursement policies and strong healthcare infrastructure. The US brain monitoring market benefits from robust research and development activities, with leading medical device manufacturers headquartered in the country.
  • The US healthcare system's emphasis on early diagnosis and continuous patient monitoring has created sustained demand for electroencephalography (EEG), functional magnetic resonance imaging (fMRI), and other advanced neuroimaging solutions.
  • Between 2023 and 2028, the US market is expected to see increased integration of artificial intelligence and machine learning in brain monitoring systems, enhancing diagnostic accuracy and clinical outcomes..

Key Market Statistics

  • CAGR (2023-2028) 4.8% CAGR
  • Market Size, 2023 ~USD 1048.7 Million
  • Forecast, 2028 ~USD 1327.5 Million
  • Country US

US Brain Monitoring Market Overview

Market Valuation :

The US brain monitoring market reached $1,048.7 million in 2023, with projected growth to $1,327.5 million by 2028, representing a steady 4.8% CAGR driven by technological advancement and clinical adoption.

Neurological Disorder Prevalence :

Rising incidence of epilepsy, stroke, traumatic brain injury, and neurodegenerative diseases across the US population is fueling demand for continuous brain monitoring solutions in hospitals and clinical settings.

Non-Invasive Technology Adoption :

US healthcare providers are increasingly adopting non-invasive brain monitoring technologies, including EEG, fNIRS, and portable devices, driven by patient safety concerns and reduced infection risk compared to invasive alternatives.

Neurocritical Care Investment :

Growing US healthcare expenditure in neurocritical care units, ICU infrastructure modernization, and reimbursement support for advanced monitoring systems are accelerating market expansion across major medical centers.

US Brain Monitoring Market Dynamics

  • Healthcare facilities are prioritizing advanced brain monitoring to improve patient outcomes in critical care settings, with non-invasive solutions gaining significant traction due to safety and efficacy advantages.
  • Reimbursement policies and insurance coverage expansion are expected to further drive adoption across hospitals and specialized neurology centers. Key growth drivers include aging demographics, rising stroke and epilepsy prevalence, and integration of AI-powered analytics in monitoring systems.
  • The US market will benefit from strong healthcare infrastructure, substantial R&D investments, and regulatory support for innovative neurotechnology.
  • However, high equipment costs and training requirements may moderate growth rates compared to global markets, maintaining the 4.8% CAGR through 2028..

Related Ecosystem

Diagnostic Imaging

Top Technologies
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • CT Scanners
  • Nuclear Imaging
  • Positron Emission Tomography
Top Companies
  • Siemens healthineers
  • PHILIPS HEALTHCARE
  • CANON INC.
  • FUJIFILM Holdings Corporation
  • UNITED IMAGING HEALTHCARE CO., LTD.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • The US brain monitoring market is valued at $1,048.7 million in 2023 and will reach $1,327.5 million by 2028.
      • The US market is growing at a 4.8% CAGR, driven by neurological disorder prevalence and advanced technology adoption.
      • The US healthcare system's focus on early diagnosis supports sustained demand for EEG, fMRI, and neuroimaging solutions.
      • AI and machine learning integration in US brain monitoring systems will enhance diagnostic accuracy through 2028.

      Brain Monitoring Market Report Scope

      Report Metric Details
      Base Year 2023
      Fastest Growing Segment CEREBRAL OXIMETERS (Type)
      Forecast Period 2023–2028
      Growth Rate CAGR of 6.3% from 2023 to 2028
      Largest Segment NON-INVASIVE PROCEDURES (Procedure)
      Market Size Base Year (Billions) ~USD 3.54 (2023)
      Revenue Forecast (Billions) ~USD 4.8 (2028)
      Segments Covered Product, Type, Usability, Procedure, Modality, Medical Condition, End User

      US Brain Monitoring Market Report Segmentation

      7 segment dimensions are covered across the global market.

      By Product

      • Accessories
      • Devices

      By Type

      • Batteries
      • Cables
      • Caps
      • Cerebral Oximeters
      • Ct Scanners
      • Dry Electrodes
      • Eeg Devices
      • Electrodes
      • Emg Devices
      • Icp Monitors
      • Meg Devices
      • Mri Scanners
      • Needle Electrodes
      • Other Accessories
      • Pastes & Gels
      • Pet Scanners
      • Sensors
      • Sleep Monitoring Devices
      • Tcd Devices
      • Wet Electrodes

      By Usability

      • Disposable Accessories
      • Non- Disposable Accessories
      • Non-Disposable Accessories

      By Procedure

      • Invasive Procedures
      • Non-Invasive Procedures

      By Modality

      • Fixed Devices
      • Portable Devices
      • Wearable Devices

      By Medical Condition

      • Dementia
      • Epilepsy
      • Headache Disorders
      • Huntington'S Disease
      • Other Medical Conditions
      • Parkinson'S Disease
      • Sleep Disorders
      • Stroke
      • Traumatic Brain Injury

      By End User

      • Ambulatory Surgery Centers & Clinics
      • Diagnostic Centers
      • Diagnostic Centres
      • Hospitals
      • Neurological Centers
      • Neurological Centres
      • Other End Users

      US: BRAIN MONITORING MARKET, BY END USER, 2021–2028

      Segment20212022202320242025202620272028CAGR (%)
      AMBULATORY SURGERY CENTERS & CLINICS132.9140.5152.1161.8172.7183.3194.6206.26.3
      DIAGNOSTIC CENTERS68.972.377.882.287.191.896.9101.95.5
      HOSPITALS685.3713.7761.1797.5837.9876916.1955.94.7
      NEUROLOGICAL CENTERS251.8267.5290.9310.9333.3355.4379.1403.66.8
      OTHER END USERS102.7105.5110.9114.6118.7122.4126.31303.2
      TOTAL1241.51299.51392.814671549.7162917131797.55.2

      Target Audience

      • Medical Device Manufacturers : Need US market data to guide product development, commercialization strategies, and competitive positioning for brain monitoring devices in a market growing at 4.8% CAGR with strong non-invasive technology demand.
      • Healthcare System Executives : Require market insights to justify capital investments in neurocritical care infrastructure, evaluate technology vendors, and benchmark adoption rates against peer institutions across US healthcare networks.
      • Investment & Private Equity Firms : Need comprehensive US market analysis to assess investment opportunities in brain monitoring startups and established companies, evaluate market growth potential, and identify acquisition targets in the neurotechnology space.
      • Clinical Research Organizations : Utilize US market data to understand adoption barriers, clinical validation requirements, and reimbursement landscapes for brain monitoring technologies in clinical trials and real-world evidence studies.
      • Healthcare Consultants & Analysts : Require detailed US market segmentation, growth drivers, and forecast data to advise healthcare clients on technology adoption strategies, market entry planning, and competitive positioning in brain monitoring.

      Key Companies in the US Brain Monitoring Market

      CompanyHQOwnershipStrongest segments
      CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic and Sports Medicine (BioBrace, Y-Knot, Hall power tools, arthroscopy ecosystem),General Surgery (AirSeal, Buffalo Filter, endomechanical, electrosurgery),Endoscopic Technologies and Patient Monitoring,
      NATUS MEDICAL INCORPORATEDUnited StatesPrivate CompanyNeurodiagnostic systems (EEG, EMG, ICU monitoring, polysomnography, intra-operative monitoring),Newborn care (hearing screening, jaundice management, brain injury, NICU essentials, NICVIEW),Audiology, otoneurologic, and vestibular systems,
      NIHON KOHDEN CORPORATIONJapanPublic CompanyPatient monitors & clinical information systems,Physiological measuring equipment (EEG/ECG/EMG and related),Defibrillators, AEDs, ventilators, anesthesia and related devices,
      GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
      SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
      COMPUMEDICS LIMITEDAustraliaPublic CompanySleep diagnostics (PSG, HST, Somfit),Neurology diagnostics (EEG, LTM, ambulatory),Brain research & MEG systems,
      MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Surgical, Monitoring, Diabetes),
      EDWARDS LIFESCIENCES CORPORATIONUnited StatesPublic CompanyTranscatheter aortic valve replacement (SAPIEN family),Transcatheter mitral and tricuspid (PASCAL, EVOQUE),Surgical structural heart (INSPIRIS, RESILIA, KONECT, MITRIS),
      CGXCanadaPublic CompanyFilm Entertainment and Content (theatrical, Event Cinema, food service),Media (on-screen, digital signage, advertising solutions),Location-Based Entertainment (Rec Room, Playdium, Junxion, in-theatre gaming),

      CONMED CORPORATION

      CONMED Corporation is a publicly traded U.S. medical device company founded in 1970 with approximately 3,900 employees.

      NATUS MEDICAL INCORPORATED

      Natus Medical Incorporated is a U.S.-based private company founded in 1987 with 1,400 employees specializing in medical devices and monitoring solutions.

      NIHON KOHDEN CORPORATION

      Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, operating in the medical device and healthcare technology industry.

      GE HEALTHCARE

      GE Healthcare is a publicly traded U.S. company established in 2022 with 54,000 employees, providing healthcare technology and solutions.

      SIEMENS HEALTHINEERS AG

      Siemens Healthineers AG is a German public company with roots dating to 1896 and 72,369 employees, operating as a global leader in medical technology and diagnostics.

      COMPUMEDICS LIMITED

      Compumedics Limited is an Australian publicly traded company founded in 1987 with 175 employees, specializing in medical device manufacturing.

      MEDTRONIC

      Medtronic is a publicly traded company founded in Ireland in 1949 with 95,000 employees, serving as a global leader in medical technology and healthcare solutions.

      EDWARDS LIFESCIENCES CORPORATION

      Edwards Lifesciences Corporation is a U.S. public company founded in 1958 with 16,000 employees, specializing in cardiovascular and critical care medical devices.

      CGX

      CGX is a Canadian public company founded in 1912 with 10,000 employees operating across multiple business sectors.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise US market valuation ($1,048.7M in 2023) and verified forecast data through 2028, enabling accurate financial planning and investment decisions for brain monitoring product launches and expansions.
      • Competitive Landscape Intelligence : Understand US-specific market dynamics, key players, and technology adoption patterns to identify competitive positioning opportunities and differentiation strategies in the non-invasive monitoring segment.
      • Regulatory & Reimbursement Insights : Access detailed analysis of US healthcare reimbursement policies, FDA approval pathways, and insurance coverage trends specific to brain monitoring devices to optimize market entry and pricing strategies.
      • Clinical Demand Drivers : Leverage data on US neurological disease prevalence, hospital adoption rates, and neurocritical care infrastructure investments to identify high-potential customer segments and geographic markets.
      • Strategic Growth Planning : Use US-focused market insights to develop targeted go-to-market strategies, partnership opportunities with healthcare systems, and product development roadmaps aligned with regional clinical needs and trends.

      Frequently asked questions

      What is the current size of the US brain monitoring market?

      The US brain monitoring market was valued at $1,048.7 million in 2023 and is expected to reach $1,327.5 million by 2028.

      What is the growth rate of the US brain monitoring market?

      The US brain monitoring market is growing at a compound annual growth rate (CAGR) of 4.8% from 2023 to 2028.

      What factors are driving growth in the US brain monitoring market?

      Growth in the US market is driven by increasing neurological disorder prevalence, rising adoption of advanced monitoring technologies, favorable reimbursement policies, and strong healthcare infrastructure investments.

      Which technologies dominate the US brain monitoring market?

      The US market is dominated by electroencephalography (EEG), functional magnetic resonance imaging (fMRI), and other advanced neuroimaging solutions integrated with AI and machine learning capabilities.

      How will the US brain monitoring market evolve by 2028?

      By 2028, the US market will see increased integration of artificial intelligence and machine learning, enhanced portability of devices, and expanded adoption in neurocritical care settings.

      RESEARCH METHODOLOGY

      The study involved four major activities in estimating the current size of the Brain Monitoring market. Exhaustive secondary research was done to collect information on the market and its different sub-segments. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and sub-segments.

      Secondary Research

      This research study involved the extensive usage of secondary sources; directories; databases such as Bloomberg Business, Factiva, and Wall Street Journal; white papers and annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the brain monitoring market. It was also used to obtain important information about the key market players, market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information important for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related executives from various key companies and organizations operating in the brain monitoring market. After the complete market engineering process (which includes calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at.

      Some of the major objectives of primary research are:

      • To validate market segmentation defined through an assessment of the product portfolios of leading players
      • To understand the key industry trends and technologies defining the strategic growth objectives of market players
      • To gather both demand- and supply-side validation of the key factors affecting the market growth
      • To validate assumptions for the market sizing and forecasting model used for this study
      • To understand the market position of leading players in the brain monitoring market and their market share/ranking

      Breakdown Of Primary Participants

      Brain Monitoring Market Size, and Share

      *Others include sales managers, marketing managers, and product managers.

      Note: Tiers are defined based on a company’s total revenue. As of 2019, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the Brain Monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.

      Bottom-up approach

      The bottom-up procedure was adopted to arrive at the overall size of the Brain Monitoring market from the revenue of key players (companies), their shares in the market, and their annual sales of Brain Monitoring products.

      Brain Monitoring Market Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Top-down approach

      The overall Brain Monitoring market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation by product, medical condition, end user, and region) through percentage splits from secondary and primary research.

      For the calculation of each type of specific market segment, the most appropriate immediate-parent market size was used for implementing the top-down approach. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Market shares were then estimated for top companies to verify the total market revenue arrived earlier in the bottom-up approach.

      Brain Monitoring Market Size, and Share

      Data Triangulation

      After arriving at the overall market size, from the market size estimation process explained above, the Brain Monitoring market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Brain Monitoring industry.

      Market Definition

      Brain Monitoring is a procedure that monitors the activity of various parameters associated with the functioning of brain, which includes electrical activity, blood flow, magnetic activity, the pressure surrounding the brain, and cerebral oxygen saturation.

      Key Stakeholders

      • World Health Organization (WHO)
      • National Center for Biotechnology Information (NCBI)
      • World Federation of Neurology (WFN)
      • Centers for Disease Control and Prevention (CDC)
      • Epilepsy Foundation
      • American Brain Foundation (ABF)
      • Brain Injury Association of America (BIAA)
      • Neurology Asia Journal
      • Alzheimer's Association
      • American Neurological Association (ANA)
      • European Journal of Neurology

      Report Objectives

      • To define, describe, and forecast the brain monitoring market based on the product, procedure, modality, medical condition, end user, and region.
      • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges).
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall brain monitoring market.
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
      • To profile the key players in the market and comprehensively analyze their market shares and core competencies.
      • To forecast the size of the market segments with respect to four main regions, namely, North America, Asia Pacific, Europe, Latin America, and Middle East & Africa.
      • To track and analyze competitive developments such as new product launches, agreements, collaborations, and expansions.

      Available Customizations:

      MarketsandMarkets offers the following customizations for this market report:

      Company Information

      • Profiling of additional market players (up to 3)
      • Additional country-level analysis of sub-segments such as media, reagents, flow cytometers, and centrifuges.

      Get the Full Brain Monitoring Market Report

      Full forecast, segment splits, and company analysis for all Brain Monitoring Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status